RxResults Announces $4 Million Financing
Leader in Pharmacy Risk Management Moves Industry Forward
LITTLE ROCK, AR – September 3 , 2014 – RxResults, LLC, a next-generation pharmacy risk management company, announced today that it has closed on a $4 million capital raise led by Ansley Equity Partners and Ansley Securities. The proceeds of this capital raise are to further accelerate the company’s growth and to expand service offerings.
Beginning with its keystone Evidence-Based Formulary Management program and extending into a range of solutions including Medication Therapy Management, Specialty Drug Management, and Prescriber Profiling, RxResults is positioned as the leading comprehensive pharmacy risk management company. “This capital raise is a confirmation and endorsement that after nearly a decade of R&D, RxResults has successfully commercialized a suite of proprietary solutions offering clients an impressive return-on-investment while improving the health status of covered members.” said Tery Baskin, CEO of RxResults.
About RxResults
RxResults is an evidence-based pharmacy risk management company. Led by an independent team of pharmacists, physicians and benefit industry experts, RxResults features an exclusive joint-collaborative with the UAMS College of Pharmacy and its Evidence-Based Medicine Center. RxResults provides comprehensive clinical and strategic expertise to identify and deliver significant and immediate savings in the areas of formulary management, medication therapy management, specialty drug management and prescriber profiling. Visit www.rxresults.com for more information.
About Ansley Equity Partners Ansley Equity Partners
(“AEP”) is a private equity firm which invests in small to mid-sized healthcare information technology and technology-enabled healthcare service companies. AEP has over 15 years experience in the healthcare-focused investment banking field. In addition to decades of experience in finance, investment banking and business strategy, AEP’s founders have extensive operating experience in healthcare and have helped build several highly successful companies. They have arranged over $1 billion in transactions for a wide variety of investors. Visit www.acgequitypartners.com for more information.
About Ansley Securities
Ansley Securities, a wholly owned subsidiary of Ansley Capital Group, is a registered broker-dealer and a member of FINRA and SIPC. Together with Ansley Capital Group, Ansley Securities provides strategic consulting, financial advisory, and investment banking services exclusively to companies in the healthcare market, including technology-enabled healthcare services and health information technology companies providing care management, clinical decision support, medical informatics, revenue cycle management, and online health content and services. Visit www.ansleycapital.com for more information.
Contacts
RxResults, LLC
Tery Baskin President/CEO
501-367-8402
tbaskin@rxresults.com
or
Ansley Equity Partners, Ansley Securities
Donald P. Carson
Member
(828) 333-4200
doncarson@ansleycapital.com
